Ioannidis and Garber describe personalised cost-effectiveness for treatments

John Ioannidis and Alan Garber, both from Stanford, have just published a new and interesting article in PLoS Medicine on individualised cost-effectiveness analysis. They think (and I agree) that knowing that it costs $8.60 to get 20 extra days without the flu is worthwhile. Especially when another example says that people over 45 with knee pain can both save $192 and get an extra 5.11 days without pain is such a nice win-win.

You can have a look at some examples of the analyses they did in the table here.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s